scPharmaceuticals

$7.38
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.11 (+1.51%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SCPH and other stocks, options, and ETFs commission-free!

About SCPH

scPharmaceuticals, Inc.engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include furosemide, used as parenteral diuretic in treating heart failure and ceftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA. The listed name for SCPH is scPharmaceuticals Inc. Common Stock.

CEO
John H. Tucker
Employees
17
Headquarters
Burlington, Massachusetts
Founded
2013
Market Cap
192.48M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
94.86K
High Today
$7.46
Low Today
$7.14
Open Price
$7.32
Volume
48.06K
52 Week High
$11.99
52 Week Low
$5.00

SCPH Earnings

-$0.58
-$0.39
-$0.19
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 24, Pre-Market

You May Also Like

OTIS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure